Live Breaking News & Updates on பணியகம் ஆஃப் மருத்துவ அறிவியல் இல் ஆரோக்கியம் கனடா

Stay updated with breaking news from பணியகம் ஆஃப் மருத்துவ அறிவியல் இல் ஆரோக்கியம் கனடா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

COVID-19: Canada Responds: Health Canada Approves Pfizer COVID-19 Vaccine for Children 12 and Older


Health Canada Approves Pfizer COVID-19 Vaccine for Children 12 and Older
In a virtual news conference, Dr. Supriya Sharma, chief medical adviser with Health Canada, and Dr. Marc Berthiaume, director of the Bureau of Medical Science at Health Canada, provide an update on regulatory authorization for the Pfizer-BioNTech COVID-19 vaccine. They announce that the agency has approved administering the vaccine to children ages 12 to 15. Pfizer is the first COVID-19 vaccine to be authorized for use with this age group in Canada. Health Canada had initially approved the use of the vaccine for people 16 years of age and older. Drs. Sharma and Berthiaume face questions about vaccine messaging after recent advice from a federal vaccine advisory panel raised concerns. At a briefing held on May 3, officials from Canada’s National Advisory Committee on Immunization (NACI) suggested that Pfizer and Moderna were the preferred COVID-19 vaccines over Johnson & Johnson and AstraZeneca for peopl ....

Marc Berthiaume , Supriya Sharma , Canada National Advisory Committee On Immunization , Bureau Of Medical Science At Health Canada , Health Canada , Health Canada Approves Pfizer , Medical Science , National Advisory Committee , மார்க் பெர்த்தியாம் , சுப்ரியா ஷர்மா , பணியகம் ஆஃப் மருத்துவ அறிவியல் இல் ஆரோக்கியம் கனடா , ஆரோக்கியம் கனடா , மருத்துவ அறிவியல் ,

COVID-19: Canada Responds: Federal Update on AstraZeneca COVID-19 Vaccine – April 14, 2021


Federal Update on AstraZeneca COVID-19 Vaccine – April 14, 2021
In a virtual news conference, Dr. Supriya Sharma, chief medical adviser with Health Canada, and Dr. Marc Berthiaume, director of the Bureau of Medical Science at Health Canada, provide an update on the use of the AstraZeneca COVID-19 vaccine in Canada. The update comes one day after the Public Health Agency of Canada reported the first case of an individual in Canada experiencing blood clots after receiving a dose of the vaccine. Health Canada concludes that these events of blood clots may be linked to the vaccine, but the agency is not restricting its use because the occurrences are very rare and officials believe the benefits of the vaccine in protecting against COVID-19 outweigh the risks. (April 14, 2021) ....

Marc Berthiaume , Supriya Sharma , Public Health Agency Of Canada , Bureau Of Medical Science At Health Canada , Health Canada , Federal Update , Medical Science , Public Health Agency , மார்க் பெர்த்தியாம் , சுப்ரியா ஷர்மா , பணியகம் ஆஃப் மருத்துவ அறிவியல் இல் ஆரோக்கியம் கனடா , ஆரோக்கியம் கனடா , கூட்டாட்சியின் புதுப்பிப்பு , மருத்துவ அறிவியல் ,